PP_1170x120_10-25-21

B. Douglas Hoey is chief executive officer of the National Community Pharmacists Association.

NCPA applauds FTC probe of PBMs

NCPA applauds FTC probe of PBMs

ALEXANDRIA, Va.  – The National Community Pharmacists Association is hailing a move by the Federal Trade Commission to proceed with a 6(b) study of pharmacy benefit managers and anticompetitive business practices. After the commission in February split 2-2 on a proposal to launch a formal study into PBMs, FTC Chair Lina Khan pledged to call for another

NCPA to CMS: Part D rule will fail to achieve goals without changes

NCPA to CMS: Part D rule will fail to achieve goals without changes

ALEXANDRIA, Va. – In comments submitted today, National Community Pharmacists Association CEO B. Douglas Hoey said independent pharmacy has strong concerns about the Centers for Medicare & Medicaid Services’ proposed Medicare Part D rule, which includes the latest efforts of the agency to lower out of pocket drug costs for patients and address pharmacy direct

Pharmacies scrambling for at-home tests, survey shows

Pharmacies scrambling for at-home tests, survey shows

ALEXANDRIA, Va. –  Pharmacists across the country are having a difficult time keeping up with the surging demand for at-home COVID-19 tests, according to a new survey by the National Community Pharmacists Association. “COVID-19 has caused shortages throughout the economy, but this is acute,” said NCPA CEO B. Douglas Hoey. “Community pharmacists are the first line of

NCPA lauds proposed elimination of retroactive fees

NCPA lauds proposed elimination of retroactive fees

ALEXANDRIA, Va. – The National Community Pharmacists Association issued the following statement today on behalf of CEO B. Douglas Hoey in response to a proposed Centers for Medicare & Medicaid Services rule posted this afternoon that would finally bring under control so-called pharmacy direct and indirect remuneration fees: “This is an encouraging development. We are grateful

Pharmacy Outlook: B. Douglas Hoey, NCPA

Pharmacy Outlook: B. Douglas Hoey, NCPA

One positive result of the coronavirus pandemic is that it has forever changed the consumer’s view of pharmacy. Of course, the evolving perception of the role of the pharmacist was already very much in progress. But the pandemic propelled it forward in ways that will have some radical effects on the business model of community

NCPA makes end of year push for N.Y. Assembly’s Pharmacy Rescue Package

NCPA makes end of year push for N.Y. Assembly’s Pharmacy Rescue Package

ALEXANDRIA, Va. – The National Community Pharmacists Association is supporting pharmacists in New York as they call for Gov. Kathy Hochul (D) to enact three bills in the Pharmacy Rescue Package and protect patient access to local pharmacy care. The bills have been sitting on Hochul’s desk for several months after the package was passed

NCPA supports bipartisan bill to ban PBM spread pricing tactics

NCPA supports bipartisan bill to ban PBM spread pricing tactics

ALEXANDRIA, Va. – The National Community Pharmacists Association is proud to support the Drug Price Transparency in Medicaid Act of 2021, which would ban the use of spread pricing by pharmacy benefit managers in Medicaid managed care, require PBMs to reimburse pharmacies at a rate consistent with their acquisition plus a professional dispensing fee, and limit PBMs

NCPA survey says majority of independent pharmacies affected by ongoing labor, supply chain issues

NCPA survey says majority of independent pharmacies affected by ongoing labor, supply chain issues

ALEXANDRIA, Va.  – A new survey of independent pharmacists released by the National Community Pharmacists Association finds that while the majority of independent pharmacy owners/managers are struggling to fill staff positions and deal with supply chain disruptions, market pressures like pharmacy benefit manager direct and indirect remuneration fees and vertical integration continue to be their

NCPA to Congress: Don’t pass the buck on DIR, spread pricing reforms

NCPA to Congress: Don’t pass the buck on DIR, spread pricing reforms

ALEXANDRIA, Va. – Ahead of expected congressional action on government spending legislation, the National Community Pharmacists Association is expressing disappointment that the House version of the reconciliation bill leaves out provisions to eliminate pharmacy benefit manager retroactive Medicare Part D pharmacy direct and indirect remuneration fees and PBM spread pricing games in Medicaid managed care

Independent pharmacy advocates submit over 3,000 comments to FTC

Independent pharmacy advocates submit over 3,000 comments to FTC

ALEXANDRIA, Va. — In addition to submitting its own comments to the Federal Trade Commission about anticompetitive pharmacy benefit manager contracting practices, the National Community Pharmacists Association encouraged independent pharmacy advocates to also submit comments with specific examples of contractual issues and the harm they cause to patients and neighborhood pharmacies. More than 3,000 advocate comments

Hoey to FTC: Investigate and fix anticompetitive PBM contracting

Hoey to FTC: Investigate and fix anticompetitive PBM contracting

ALEXANDRIA, Va.  — The vertical mergers of health insurance plans/pharmacy benefit managers with retail and mail order pharmacies is a “particularly pernicious example of consolidation that has resulted in substantial actual harm to competition,” the National Community Pharmacists Association said in comments to the Federal Trade Commission about contract terms that may exacerbate or lock

Community pharmacy makes goal line push to eliminate PBM spread pricing

Community pharmacy makes goal line push to eliminate PBM spread pricing

ALEXANDRIA, Va.  — The National Community Pharmacists Association is using social media, digital advertising, and a grassroots effort to push congressional budget makers to include a provision eliminating pharmacy benefit manager spread pricing under the Medicaid program and reimburse pharmacies in a fairer and more transparent manner. “PBM spread pricing costs federal and state taxpayers

NCPA on Biden drug pricing plan: Include PBMs/insurers to truly lower costs

NCPA on Biden drug pricing plan: Include PBMs/insurers to truly lower costs

ALEXANDRIA, Va. — National Community Pharmacists Association CEO B. Douglas Hoey, pharmacist, MBA issued the following statement today in response to President Biden’s drug pricing remarks: “The president’s plan takes a swing at lowering drug prices and whiffs by ignoring the most glaring cause of high drug costs. Pharmacy benefit managers and their insurer-partner/owners continue to

Pharmacies need help before the next emergency

Pharmacies need help before the next emergency

This time last year, COVID-19 vaccines felt to many of us like a rather distant prospect. Community pharmacy teams were in the thick of offering home deliveries to patients, working with their drive-thru and curbside services, and compounding hand sanitizer for first responders and patients. Many were also gearing up their COVID-19 testing and scheduling